209 related articles for article (PubMed ID: 29696364)
1. Differential somatostatin, CXCR4 chemokine and endothelin A receptor expression in WHO grade I-IV astrocytic brain tumors.
Lange F; Kaemmerer D; Behnke-Mursch J; Brück W; Schulz S; Lupp A
J Cancer Res Clin Oncol; 2018 Jul; 144(7):1227-1237. PubMed ID: 29696364
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin and chemokine CXCR4 receptor expression in pancreatic adenocarcinoma relative to pancreatic neuroendocrine tumours.
Kajtazi Y; Kaemmerer D; Sänger J; Schulz S; Lupp A
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2481-2493. PubMed ID: 31451931
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of sst1, sst2A, and sst3 somatostatin receptor proteins in low-grade and high-grade astrocytomas.
Mawrin C; Schulz S; Pauli SU; Treuheit T; Diete S; Dietzmann K; Firsching R; Schulz S; Höllt V
J Neuropathol Exp Neurol; 2004 Jan; 63(1):13-9. PubMed ID: 14748557
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of somatostatin, CXCR4 chemokine and endothelin A receptor expression in a large set of paragangliomas.
Kaemmerer D; Sänger J; Arsenic R; D'Haese JG; Neumann J; Schmitt-Graeff A; Wirtz RM; Schulz S; Lupp A
Oncotarget; 2017 Oct; 8(52):89958-89969. PubMed ID: 29163802
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin and CXCR4 expression patterns in adenocarcinoma and squamous cell carcinoma of the lung relative to small cell lung cancer.
Stumpf C; Kaemmerer D; Neubauer E; Sänger J; Schulz S; Lupp A
J Cancer Res Clin Oncol; 2018 Oct; 144(10):1921-1932. PubMed ID: 30076481
[TBL] [Abstract][Full Text] [Related]
6. Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status.
Faria MH; Gonçalves BP; do Patrocínio RM; de Moraes-Filho MO; Rabenhorst SH
Neuropathology; 2006 Dec; 26(6):519-27. PubMed ID: 17203587
[TBL] [Abstract][Full Text] [Related]
7. Expression and Prognostic Value of Oct-4 in Astrocytic Brain Tumors.
Krogh Petersen J; Jensen P; Dahl Sørensen M; Winther Kristensen B
PLoS One; 2016; 11(12):e0169129. PubMed ID: 28030635
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of somatostatin and CXCR4 receptor expression in different types of thyroid carcinoma using well-characterised monoclonal antibodies.
Czajkowski M; Kaemmerer D; Sänger J; Sauter G; Wirtz RM; Schulz S; Lupp A
BMC Cancer; 2022 Jul; 22(1):740. PubMed ID: 35799158
[TBL] [Abstract][Full Text] [Related]
9. Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their origin.
Mai R; Kaemmerer D; Träger T; Neubauer E; Sänger J; Baum RP; Schulz S; Lupp A
Sci Rep; 2019 Mar; 9(1):4339. PubMed ID: 30867449
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets.
Kaemmerer D; Schindler R; Mußbach F; Dahmen U; Altendorf-Hofmann A; Dirsch O; Sänger J; Schulz S; Lupp A
BMC Cancer; 2017 Dec; 17(1):896. PubMed ID: 29282035
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Somatostatin and CXCR4 Receptor Expression in a Large Set of Prostate Cancer Samples Using Tissue Microarrays and Well-Characterized Monoclonal Antibodies.
Werner C; Dirsch O; Dahmen U; Grimm MO; Schulz S; Lupp A
Transl Oncol; 2020 Sep; 13(9):100801. PubMed ID: 32460182
[TBL] [Abstract][Full Text] [Related]
12. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma.
Rempel SA; Dudas S; Ge S; Gutiérrez JA
Clin Cancer Res; 2000 Jan; 6(1):102-11. PubMed ID: 10656438
[TBL] [Abstract][Full Text] [Related]
13. Expression of somatostatin receptor subtypes in human brain tumors.
Dutour A; Kumar U; Panetta R; Ouafik L; Fina F; Sasi R; Patel YC
Int J Cancer; 1998 May; 76(5):620-7. PubMed ID: 9610716
[TBL] [Abstract][Full Text] [Related]
14. Comparison of somatostatin receptor expression in human gliomas and medulloblastomas.
Cervera P; Videau C; Viollet C; Petrucci C; Lacombe J; Winsky-Sommerer R; Csaba Z; Helboe L; Daumas-Duport C; Reubi JC; Epelbaum J
J Neuroendocrinol; 2002 Jun; 14(6):458-71. PubMed ID: 12047721
[TBL] [Abstract][Full Text] [Related]
15. Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin.
Stollberg S; Kämmerer D; Neubauer E; Schulz S; Simonitsch-Klupp I; Kiesewetter B; Raderer M; Lupp A
J Cancer Res Clin Oncol; 2016 Nov; 142(11):2239-47. PubMed ID: 27544389
[TBL] [Abstract][Full Text] [Related]
16. A Critical Evaluation of sst3 and sst5 Immunohistochemistry in Human Pituitary Adenomas.
Körner M; Waser B; Christ E; Beck J; Reubi JC
Neuroendocrinology; 2018; 106(2):116-127. PubMed ID: 28384628
[TBL] [Abstract][Full Text] [Related]
17. Expression patterns of Wnt signaling component, secreted frizzled‑related protein 3 in astrocytoma and glioblastoma.
Pećina-Šlaus N; Kafka A; Varošanec AM; Marković L; Krsnik Ž; Njirić N; Mrak G
Mol Med Rep; 2016 May; 13(5):4245-51. PubMed ID: 27035837
[TBL] [Abstract][Full Text] [Related]
18. Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value.
Rosager AM; Sørensen MD; Dahlrot RH; Hansen S; Schonberg DL; Rich JN; Lathia JD; Kristensen BW
PLoS One; 2017; 12(8):e0182954. PubMed ID: 28837569
[TBL] [Abstract][Full Text] [Related]
19. Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy.
Kaemmerer D; Träger T; Hoffmeister M; Sipos B; Hommann M; Sänger J; Schulz S; Lupp A
Oncotarget; 2015 Sep; 6(29):27566-79. PubMed ID: 26259237
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas.
Baumgarten P; Blank AE; Franz K; Hattingen E; Dunst M; Zeiner P; Hoffmann K; Bähr O; Mäder L; Goeppert B; Machein M; Seifert V; Steinbach JP; Plate KH; Harter PN; Mittelbronn M
Neuro Oncol; 2016 Feb; 18(2):173-83. PubMed ID: 26627848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
